A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma.

Q1 Medicine
Neurosignals Pub Date : 2022-11-11 DOI:10.33594/000000585
Argyrios Chronopoulos, Neele Babst, Christian Schiemenz, James S Schutz, Ludwig M Heindl, Mahdy Ranjbar, Vinodh Kakkassery
{"title":"A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma.","authors":"Argyrios Chronopoulos,&nbsp;Neele Babst,&nbsp;Christian Schiemenz,&nbsp;James S Schutz,&nbsp;Ludwig M Heindl,&nbsp;Mahdy Ranjbar,&nbsp;Vinodh Kakkassery","doi":"10.33594/000000585","DOIUrl":null,"url":null,"abstract":"<p><p>Retinoblastoma (RB) management has evolved over the last three decades. Goals of modern RB treatment are first to protect life and prevent metastatic disease, then preservation of the globe and useful vision. With modern treatment protocols and early disease detection success rates can reach up to 100% of disease-free-globe and eye preservation. Treatment of advanced cases remains complex, requiring aggressive chemotherapy or/and external beam radiation. Treatment protocols are extremely diverse and dependent on local resources thus success rates are variable. Here we review narratively current treatment protocols and failure rates based on a PubMed search using keywords of retinoblastoma, retinoblastoma seed, retinoblastoma treatment, enucleation.</p>","PeriodicalId":19171,"journal":{"name":"Neurosignals","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosignals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33594/000000585","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

Abstract

Retinoblastoma (RB) management has evolved over the last three decades. Goals of modern RB treatment are first to protect life and prevent metastatic disease, then preservation of the globe and useful vision. With modern treatment protocols and early disease detection success rates can reach up to 100% of disease-free-globe and eye preservation. Treatment of advanced cases remains complex, requiring aggressive chemotherapy or/and external beam radiation. Treatment protocols are extremely diverse and dependent on local resources thus success rates are variable. Here we review narratively current treatment protocols and failure rates based on a PubMed search using keywords of retinoblastoma, retinoblastoma seed, retinoblastoma treatment, enucleation.

视网膜母细胞瘤的治疗选择和治疗失败。
视网膜母细胞瘤(RB)的管理在过去的三十年中不断发展。现代RB治疗的目标首先是保护生命和预防转移性疾病,然后是保存全球和有用的视力。随着现代治疗方案和早期疾病检测的成功率可以达到100%的无病全球和眼睛保护。晚期病例的治疗仍然复杂,需要积极的化疗或/和外部放射治疗。治疗方案非常多样化,依赖于当地资源,因此成功率是可变的。在这里,我们回顾了目前的治疗方案和失败率基于PubMed搜索关键词视网膜母细胞瘤,视网膜母细胞瘤种子,视网膜母细胞瘤治疗,去核。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurosignals
Neurosignals 医学-神经科学
CiteScore
3.40
自引率
0.00%
发文量
3
审稿时长
>12 weeks
期刊介绍: Neurosignals is an international journal dedicated to publishing original articles and reviews in the field of neuronal communication. Novel findings related to signaling molecules, channels and transporters, pathways and networks that are associated with development and function of the nervous system are welcome. The scope of the journal includes genetics, molecular biology, bioinformatics, (patho)physiology, (patho)biochemistry, pharmacology & toxicology, imaging and clinical neurology & psychiatry. Reported observations should significantly advance our understanding of neuronal signaling in health & disease and be presented in a format applicable to an interdisciplinary readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信